Glycans in Diseases and Therapeutics

Glycomedicine plays major role in cell-cell adhesion i.e. a method used by cells of the immune system via sugar-binding proteins called lectins, which identifies specific carbohydrate moieties. Glycan’s (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play major roles in many biological phenomena as well as in various pathophysiological processes. Many scientists in other fields of research have now realized that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is an important field of research and sometimes they require a glycobiology and/or glycochemistry approach to be used.

  • Congenital disorders of glycosylation (CDG)
  • Cardiovascular diseases
  • Cancer biomarkers
  • Cancer associated coagulopathies
  • Transfusion medicine
  • Cardiac arrest
  • Glycomedicine

Related Conference of Glycans in Diseases and Therapeutics

September 18-20, 2017

9th International Conference on Structural Biology

Zurich, Switzerland
September 21-22, 2017

International Conference on Glycobiology

Houston, Texas, USA
September 28-29, 2017

2nd International Conference on Biochemistry

Dubai, UAE
October 25-26, 2017

Global Proteomics Conference

Dubai, UAE
October 30 - November 01, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 13-15, 2017

9th International Conference and Expo on Proteomics

Paris, France
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy

Glycans in Diseases and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in